Replimune Group, Inc. Operating Income

Quick Answer

Replimune Group, Inc. reported Operating Income of -$261.63 million for fiscal year 2025.

Replimune Group, Inc. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$261.63M -11.4%
2024 -$234.77M -32.6%
2023 -$177.08M -49.7%
2022 -$118.31M -48.0%
2021 -$79.95M -42.3%
2020 -$56.20M -81.6%
2019 -$30.95M -60.9%
2018 -$19.23M -99.3%
2017 -$9.65M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
December 31, 2025 -$71.87M -8.9% +14.7%
September 30, 2025 -$84.29M -43.1% +6.8%
June 30, 2025 -$90.42M -57.6% -37.0%
December 31, 2024 -$66.02M -16.8% -12.1%
September 30, 2024 -$58.92M +7.7% -2.7%
June 30, 2024 -$57.37M -3.1% -1.5%
December 31, 2023 -$56.54M -35.8% +11.4%
September 30, 2023 -$63.83M -53.5% -14.7%
  • Replimune Group, Inc. showed a decrease of -11.4% in Operating Income compared to the prior fiscal year.
  • Over the 2017–2025 period, Replimune Group, Inc.’s operating income has declined by 2612.0% (from -$9.65 million to -$261.63 million).
  • The most recent figure is from Replimune Group, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 22, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment